Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive

Fig. 2

Viability of Hepa1–6 cells treated with BCP NPs under gradient concentrations (a) and different drugs for 24 h and 48 h (b); viability of Hepa1–6 cells incubated with blank PLGA NPs at different concentrations for 24 h and 48 h (c); Fluorescence images of Hepa1–6 cells tumor cells after various treatments analyzed by JC-1 staining (scale bar: 20 µm, JC-1/A and JC-1/M signified the aggregate and monomer form of JC-1 (d); Flow cytometry analysis of cell apoptosis by staining with Alexa Fluor 488 annexin V-FITC and PI after various treatments (e)

Back to article page